AAAAAA
Results:
1-22
|
Results: 22
Authors:
Shin, I
Bakin, AV
Rodeck, U
Brunet, A
Arteaga, CL
Citation: I. Shin et al., Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1, MOL BIOL CE, 12(11), 2001, pp. 3328-3339
Authors:
Bhowmick, NA
Ghiassi, M
Bakin, A
Aakre, M
Lundquist, CA
Engel, ME
Arteaga, CL
Moses, HL
Citation: Na. Bhowmick et al., Transforming growth factor-beta 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism, MOL BIOL CE, 12(1), 2001, pp. 27-36
Authors:
Arteaga, CL
Johnson, DH
Citation: Cl. Arteaga et Dh. Johnson, Tyrosine kinase inhibitors-ZD1839 (Iressa), CURR OPIN O, 13(6), 2001, pp. 491-498
Authors:
Arteaga, CL
Citation: Cl. Arteaga, The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia, J CL ONCOL, 19(18), 2001, pp. 32S-40S
Authors:
Busse, D
Yakes, FM
Lenferink, AEG
Arteaga, CL
Citation: D. Busse et al., Tyrosine kinase inhibitors: Rationale, mechanisms of action, and implications for drug resistance, SEMIN ONCOL, 28(5), 2001, pp. 47-55
Authors:
Muraoka, RS
Lenferink, AEG
Simpson, J
Brantley, DM
Roebuck, LR
Yakes, FM
Arteaga, CL
Citation: Rs. Muraoka et al., Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function, J CELL BIOL, 153(5), 2001, pp. 917-931
Authors:
McEarchern, JA
Kobie, JJ
Mack, V
Wu, RS
Meade-Tollin, L
Arteaga, CL
Dumont, N
Besselsen, D
Seftor, E
Hendrix, MJC
Katsanis, E
Akporiaye, ET
Citation: Ja. Mcearchern et al., Invasion and metastasis of a mammary tumor involves TGF-beta signaling, INT J CANC, 91(1), 2001, pp. 76-82
Authors:
Lenferink, AEG
Busse, D
Flanagan, WM
Yakes, FM
Arteaga, CL
Citation: Aeg. Lenferink et al., ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways, CANCER RES, 61(17), 2001, pp. 6583-6591
Authors:
Dumont, N
Arteaga, CL
Citation: N. Dumont et Cl. Arteaga, Transforming growth factor-beta and breast cancer - Tumor promoting effects of transforming growth factor-beta, BREAST CA R, 2(2), 2000, pp. 125-132
Authors:
Gobbi, H
Arteaga, CL
Jensen, RA
Simpson, JF
Dupont, WD
Olson, SJ
Schuyler, PA
Plummer, WD
Page, DL
Citation: H. Gobbi et al., Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas, HISTOPATHOL, 36(2), 2000, pp. 168-177
Authors:
Busse, D
Doughty, RS
Arteaga, CL
Citation: D. Busse et al., HER-2/neu (erbB-2) and the cell cycle, SEMIN ONCOL, 27(6), 2000, pp. 3-8
Authors:
Lenferink, AEG
Simpson, JF
Shawver, LK
Coffey, RJ
Forbes, JT
Arteaga, CL
Citation: Aeg. Lenferink et al., Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu plus MMTV/TGF-alpha bigenic mice, P NAS US, 97(17), 2000, pp. 9609-9614
Authors:
Bakin, AV
Tomlinson, AK
Bhowmick, NA
Moses, HL
Arteaga, CL
Citation: Av. Bakin et al., Phosphatidylinositol 3-kinase function is required for transforming growthfactor beta-mediated epithelial to mesenchymal transition and cell migration, J BIOL CHEM, 275(47), 2000, pp. 36803-36810
Authors:
Busse, D
Doughty, RS
Ramsey, TT
Russell, WE
Price, JO
Flanagan, WM
Shawver, LK
Arteaga, CL
Citation: D. Busse et al., Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity, J BIOL CHEM, 275(10), 2000, pp. 6987-6995
Authors:
Arteaga, CL
Citation: Cl. Arteaga, Epidermal growth factor receptor-targeted approaches for anticancer therapy: Focus on ZD1839 - A seminar-in-print - Foreword, DRUGS, 60, 2000, pp. NIL_5-NIL_5
Authors:
Kurokawa, H
Lenferink, AEG
Simpson, JF
Pisacane, PI
Sliwkowski, MX
Forbes, JT
Arteaga, CL
Citation: H. Kurokawa et al., Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-ovorexpresessed tamoxifen-resistant breast cancer cells, CANCER RES, 60(20), 2000, pp. 5887-5894
Authors:
Gobbi, H
Dupont, WD
Simpson, JF
Plummer, WD
Schuyler, PA
Olson, SJ
Arteaga, CL
Page, DL
Citation: H. Gobbi et al., Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia, J NAT CANC, 91(24), 1999, pp. 2096-2101
Authors:
Arteaga, CL
Koli, KM
Dugger, TC
Clarke, R
Citation: Cl. Arteaga et al., Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta, J NAT CANC, 91(1), 1999, pp. 46-53
Authors:
Arteaga, CL
Citation: Cl. Arteaga, Introduction - Foundations of molecular therapies in breast carcinoma, J MAMMARY G, 4(4), 1999, pp. 333-335
Authors:
Srivastava, DK
Husain, I
Arteaga, CL
Wilson, SH
Citation: Dk. Srivastava et al., DNA polymerase beta expression differences in selected human tumors and cell lines, CARCINOGENE, 20(6), 1999, pp. 1049-1054
Authors:
Koli, KM
Arteaga, CL
Citation: Km. Koli et Cl. Arteaga, Transforming growth factor-beta and breast cancer, CONT CANC R, 3, 1999, pp. 95-119
Authors:
Ohmori, T
Yang, JL
Price, JO
Arteaga, CL
Citation: T. Ohmori et al., Blockade of tumor cell transforming growth factor-beta s enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy, EXP CELL RE, 245(2), 1998, pp. 350-359
Risultati:
1-22
|